Paxman announces multi centre FDA trial for the prevention of chemotherapy induced alopecia
11/15/2013
Paxman, the leading global expert and supplier in scalp cooling for cancer chemotherapy patients, has been granted Investigational Device Exemption (IDE) Approval by the U.S. Food and Drug Administration FDA ahead of a multi-centre, randomized trial of the patented Paxman scalp cooling system for the prevention of chemotherapy induced alopecia.
New-found signalling role for carbon dioxide could be applied to blood flow, birth and deafness
11/15/2013
New research reveals exactly how the body measures carbon dioxide and suggests that far from being a metabolic waste product, it could play a key role as a biological signalling molecule.
Low-intensity therapy for Burkitt lymphoma found to be highly effective
11/15/2013
Adult patients with a type of cancer known as Burkitt lymphoma had excellent long-term survival rates - upwards of 90 percent - following treatment with low-intensity chemotherapy regimens, according to a new clinical trial finding.
Common chemo drug thwarts graft rejection in bone marrow transplants
11/15/2013
Results of a Johns Hopkins study may explain why a chemotherapy drug called cyclophosphamide prevents graft-versus-host (GVHD) disease in people who receive bone marrow transplants. The experiments point to an immune system cell that evades the toxic effects of cyclophosphamide and protects patients from a lethal form of GVHD.
Cancer, arthritis treatments could target same 'glue' molecule
11/15/2013
Two very different diseases, rheumatoid arthritis and some cancers, share a common feature - an over-abundance of a "glue" molecule that helps cells stick together. Now, a new study suggests targeting this molecule could help treat both.
A University of Colorado Cancer Center study recently published in the journal Physics in Medicine and Biology shows that endorectal balloons commonly used during precise radiation treatment for prostate cancer can deform the prostate in a way that could make radiation miss its mark."Use of a balloon allows you to stabilize the anatomy.
Development of early immune system studied
11/14/2013
Researchers at Lund University have shed light on how and when the immune system is formed, raising hope of better understanding various diseases in children, such as leukaemia.The immune system is complex and a number of genetic diseases are attributed to defects in the cells that form its origins.
Potential new use for old drugs
11/14/2013
A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.Researchers discovered that simple modifications to the drug furamidine have a major impact on its ability to affect specific human proteins involved in the on-off switches of certain genes.
Eradicating brain tumours using biomaterial-delivered chemotherapy
11/14/2013
A polymer originally designed to help mend broken bones could be successful in delivering chemotherapy drugs directly to the brains of patients suffering from brain tumours, researchers at The University of Nottingham have discovered.
Detecting breast-cancer related lymphedema - a new solution
11/14/2013
Findings suggest affective reliable and accurate measurement of Lymphedema may help ease breast-cancer survivors fearsViewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema - a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.